Back

The effect of oral anticoagulants on the incidence of dementia in patients with atrial fibrillation: a systematic review and meta-analysis

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Antithrombotic and anticoagulant therapy in special populations Anticoagulants ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Sebastian Mactaggart

Northumbria Healthcare, Newcastle-Upon-Tyne (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Direct oral anticoagulants exhibit lower risks of mortality and bleeding compared to vitamin-k antagonists in atrial fibrillation patients on chronic hemodialysis: a meta-analysis
Doctor H. Jain (Jodhpur, IN)
Abstract Slides Video
Presentation thumbnail
Medication adherence and antithrombotic therapy outcomes: insights from a post-hoc analysis of the AFIRE trial
Doctor N. Chiba (Sendai, JP)
Abstract Slides Video
Presentation thumbnail
Impact of differences in body mass index, body surface area and lean body mass on clinical outcomes in patients with atrial fibrillation receiving edoxaban: 4-year follow-up data from ETNA-AF-Europe
Professor G. Boriani (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Haemorrhagic risk in elderly patients with atrial fibrillation that develop low platelet count during direct oral anticoagulant treatment: insights from the ATHERO-AF study.
Doctor D. Menichelli (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Silent cerebral microvascular disease and longitudinal risk of cognitive decline in atrial fibrillation
Associate Professor Y. Kondo (Chiba, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Antithrombotic and anticoagulant therapy in special populations

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Incidence, management and outcomes of patients with incident atrial fibrillation in the contemporary direct oral anti coagulants era. A national study
thumbnail
Congress Presentation
Risk factor management and cognitive function in patients with atrial fibrillation
thumbnail
Congress Presentation
Risk and benefits of baseline antiplatelet therapy in 58,598 patients with atrial fibrillation randomized to NOACs vs warfarin

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources